Earlier this month, AVAC hosted a webinar to explain and explore the complex issues of hormonal contraceptives and HIV risk in light of a new analysis that is generating plenty of debate. New findings raise increased concern that one type of hormonal contraceptive, known as Depo-Provera, may raise a woman’s risk of acquiring HIV. At the same time, Depo-Provera has been an effective way for a generation of African women to control their reproductive health. The debate surrounding Depo-Provera has been passionate and comes at a time when a number of influential voices are calling for a paradigm shift that would align scientific research with the health needs of women.
Jeanne Baron
AVAC
Read the full article here.
